Fri May 22 19:28:26 SGT 2015  
    STD (Sexually Transmitted Disease), Sri Lanka
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment
28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing

STD (Sexually Transmitted Disease), Sri Lanka


STD (Sexually Transmitted Disease), Sri Lanka @std_info: STD (Sexually Transmitted Disease) symptoms in men/women, screening/diagnosis, testing/check and treatment, Sri Lanka - Private and confidential service.

Keywords: STD (Sexually Transmitted Disease) Sri Lanka, Sri Lanka STD (Sexually Transmitted Disease), STD (Sexually Transmitted Disease).


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: STD (Sexually Transmitted Disease), Sri Lanka
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference

Latest News

The Important Role of Nursing in Primary Care Exploring Knowledge About Human Immunodeficiency Virus and Other Sexually Transmitted Diseases in Adolescents
Wed, 20 May 2015 20:42:54 +0100 | Journal of Adolescent Health
It is with great interest that we have read the article by Pedro-Espada et al. [1]. First, we would like to offer our compliments to the authors for their work. (Source: Journal of Adolescent Health)

[Research Articles] Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections
Wed, 20 May 2015 00:00:00 +0100 | Science Translational Medicine
The antibiotic spectinomycin is a potent inhibitor of bacterial protein synthesis with a unique mechanism of action and an excellent safety index, but it lacks antibacterial activity against most clinically important pathogens. A series of N-benzyl–substituted 3'-(R)-3'-aminomethyl-3'-hydroxy spectinomycins was developed on the basis of a computational analysis of the aminomethyl spectinomycin binding site and structure-guided synthesis. These compounds had ribosomal inhibition values comparable to spectinomycin but showed increased potency against the common respiratory tract pathogens Streptococcus pneumoniae, Haemophilus influenzae, Legionella pneumophila, and Moraxella catarrhalis, as well as the sexually transmitted bacteria Neisseria gonorrhoeae and Chlamydia trachomatis. Non&n...

Nigeria: HIV/Aids Blamed for 59.3 Percent Female Deaths in Four Yrs - Report
Tue, 19 May 2015 09:02:44 +0100 | AllAfrica News: HIV-Aids and STDs
[Daily Trust] HIV/AIDS accounted for 59.3 percent of female deaths recorded in Nigeria for four years on the average according to figures released by the National Bureau of Statistics (NBS). (Source: AllAfrica News: HIV-Aids and STDs)

Highlights from this issue
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
In 1970, the US Surgeon General is said to have declared that it was time to "close the book on infectious diseases, declare the war against pestilence won and shift national resources to such chronic problems as cancer and heart disease". Though this attribution has been disputed,1 the undoubted optimism of that era over infectious disease now seems a world away, after a year in which Ebola both reached and was transmitted within the United States of America. In recent years we have been alarmed by the re-emergence of ancient diseases in newly resistant form—particularly gonorrhoea and tuberculosis. This month, Tuddenham and Ghanem's editorial introduces a mini-series on the threat of antimicrobial resistant (AMR) gonorrhoea,2 featuring expert analyses by international experts Rice,...

Exploring the implications of HPV infection for head and neck cancer
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
Over recent years, human papillomavirus (HPV) has been shown to be a major risk factor for head and neck squamous cell cancer (HNSCC), and particularly oropharyngeal squamous cell carcinoma.1 2 In 2007, the International Agency for Research on Cancer recognised HPV as a carcinogen associated with malignant transformation in this subset of head and neck cancers. It is now well established that HPV-induced oropharyngeal cancers and those caused by other factors (such as smoking and alcohol abuse—a combination of heavy smoking and drinking leads to an almost 50-fold increased risk of oral and pharyngeal cancer3) are two separate entities, with distinct aetiologies, clinical characteristics, prognoses and a different epidemiology and molecular basis.4 The incidence of HPV-associated HNSC...

Spotting the Signs: a national toolkit to help identify young people at risk of child sexual exploitation
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
It has been widely reported in research and inquiries that child sexual exploitation (CSE) is both under-reported and unrecognised by statutory and voluntary sector organisations.1–3 A report by the Office of the Children's Commissioner found that at least 16 500 children were identified as being at risk of CSE each year by gangs and groups.1 Between 5% and 17% of children under 16 (between 650 000 and 2 million children) experience sexual abuse, and more than one in three do not tell anyone during childhood.2 CSE has been defined by the National Working Group for Sexually Exploited Children and Young People3 as the involvement of those aged <18 in exploitative situations, contexts and relationships where the young people (or a third person) receive something (eg, affect...

Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
Neisseria gonorrhoeae is associated with high morbidity worldwide. The emergence of cephalosporin and macrolide resistance represents a grave threat to the control of a disease, which, if untreated, can lead to serious reproductive complications in women, blindness in neonates, facilitated spread of HIV and, in rare cases, life-threatening disseminated infections.1 2 A plenary was convened at the Centers for Disease Control and Prevention's (CDC) sexually transmitted disease (STD) Prevention Conference held in Atlanta, Georgia, 9–12 June 2014, to discuss several key aspects pertaining to this issue. The Scientific Committee, including Drs Matthew Golden from the University of Washington, Kevin Karem from CDC and Khalil Ghanem from Johns Hopkins University School of Medicine, invited ...

Results of a pilot screening programme for genital and extragenital gonococcal and chlamydial infections in a military population following the repeal of 'Don't Ask, Don't Tell'
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
In the care of the active duty HIV-positive population, there has been a shift in evaluation and data with the Department of Defense repeal of the ‘don't ask, don't tell’ (DADT) policy in September 2011.1 DADT allowed homosexual persons to serve in the military, but made it unlawful for service members to be asked about their orientation or for them to reveal their orientation. This policy made it difficult to screen for asymptomatic rectal and pharyngeal STIs. Since the repeal, service members are now able to reveal their sexual orientation without concern for repercussion. Since September 2011, additional nucleic acid amplification test based screening of rectal and pharyngeal Neisseria gonorrhoeae (NG)/Chlamydia trachomatis (CT) was offered to patients at their biannual visi...

Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
Gonorrhoea is an important sexually transmitted infection associated with serious complications and enhanced HIV transmission. Oropharyngeal infections are often asymptomatic and will only be detected by screening. Gonococcal culture has low sensitivity (<50%) for detecting oropharyngeal gonorrhoea, and, although not yet approved commercially, nucleic acid amplification tests (NAAT) are the assay of choice. Screening for oropharyngeal gonorrhoea should be performed in high-risk populations, such as men-who-have-sex-with-men(MSM). NAATs have a poor positive predictive value when used in low-prevalence populations. Gonococci have repeatedly thwarted gonorrhoea control efforts since the first antimicrobial agents were introduced. The oropharyngeal niche provides an enabling environment for...

Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
Tue, 19 May 2015 00:00:00 +0100 | Sexually Transmitted Infections
The history of antimicrobial therapy of Neisseria gonorrhoeae infections has been one of recurrent development of resistance towards the antibiotics recommended as first-line therapies.1 2 The initial discovery of penicillin was lifesaving for those who suffered from serious staphylococcal and streptococcal infections, but also provided the first truly effective therapy against disseminated gonococccal infections. The emergence of gonococcal penicillin resistance associated with increasing clinical use of penicillin to treat gonococcal infections led to more use of tetracycline for treatment, which was associated with the emergence and spread of tetracycline resistance. Similarly for the use of spectinomycin. Once prevalent, resistance determinants persist even when use of the associated a...